A Winning Client Experience for High-Net-Worth Women

Published on July 2, 2023

Continue reading on website
Other news

Robinson-Patman Act Revival: Implications for Consumer Products Manufacturers

July 2, 2023
Recent reports indicate that the Federal Trade Commission (FTC) is starting to scrutinize manufacturers in the consumer package goods (CPG) industry for potential price discrimination against retail channel partners under the Robinson-Patman Act (RPA). Over the past month, the FTC has reached out to numerous retail partners, to obtain information around how they purchase and how much they pay for

Implications of Inflation Reduction Act negotiation - the known unknowns

July 3, 2023
The Inflation Reduction Act could be the most significant development in the US pharma and biotech market since the creation of Medicare Part D. We’re here to help you understand the impact on your brands.In our previous articles, we discussed the impact of the Inflation Reduction Act on US healthcare and how to prepare for the Medicare Drug Price negotiation process. In this article, we address s